Spots Global Cancer Trial Database for Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

Official Title: Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

Study ID: NCT00591643

Conditions

Adrenal Tumors

Adrenal Malignancies

Abnormal Hormonal Secretions

Electrolytes Abnormalities

Interventions

Imaging, Adrenal acans

(NP-59)

Study Description

Brief Summary: The purpose of this study is to find out if your adrenal glands are normal or abnormal. This can be determined by whether or not your adrenal gland concentrates more of a labeled building block of adrenal hormone, norcholesterol. This labeled material had been used as an investigative diagnostic tool for imaging adrenal glands for many years with success in our hands. This is a diagnostic procedure. CT, MRI and Ultrasound can determine the size and presence or absence of tumor but cannot assess the function of the adrenal glands. To determine hormone concentrations from blood samples would involve more invasive catherization.

Detailed Description: To investigate the feasibility of using NP-59 to localize adrenal tumors and assess their functions under the influence of pharmacological manipulations.